Prothena Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 66
Employees
  • Stock Symbol
  • PRTA
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $74.81
  • (As of Monday Closing)

Prothena General Information

Description

Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Contact Information

Website
prothena.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • Alexandra House
  • The Sweepstakes, Ballsbridge
  • Dublin 4
  • Ireland
+353 (01) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prothena Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$74.81 $77.07 $9.67 - $78.40 $3.47B 45M 442K -$1.75

Prothena Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,944,585 184,092 265,422 10,997
Revenue 60,748 853 814 955
EBITDA (58,488) (105,819) (78,681) (155,591)
Net Income (70,386) (111,144) (77,677) (155,645)
Total Assets 436,378 332,975 419,268 498,796
Total Debt 15,149 17,838 22,939 51,546
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Prothena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prothena‘s full profile, request access.

Request a free trial

Prothena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel prote
Biotechnology
Dublin, Ireland
66 As of 2020
00000
0.000 0000-00-00
00000000 00000

00000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000000000000
Thousand Oaks, CA
00000 As of 0000
00.000
000000000000 00.000

00000 00

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000 000000000
New York, NY
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Prothena Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
00000 000000000000 Formerly VC-backed Waltham, MA 00 00000 00000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Prothena Executive Team (17)

Name Title Board Seat Contact Info
Gene Kinney Ph.D Chief Executive Officer & Board Member
Tran Nguyen Chief Financial Officer, Finance & Chief Operating Officer, Operations
Karin Walker Chief Accounting Officer, Accounting & Controller, Finance
Michael Malecek JD Secretary, Administration & Chief Legal Officer, Legal
Wagner Zago Ph.D Chief Scientific Officer
You’re viewing 5 of 17 executive team members. Get the full list »

Prothena Board Members (13)

Name Representing Role Since
000000 0000000000 00.0 Prothena Board Member 000 0000
00000000000 000000 00.0 Self Board Member 000 0000
000000 000000 00 Self Board Member 000 0000
0000 000000 00.0 Prothena Chief Executive Officer & Board Member 000 0000
0000 00000 00.0 Self Chairman of the Board 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Prothena Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prothena Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 14-Sep-2021 000 000.00 Drug Discovery
To view Prothena’s complete investments history, request access »